These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 21700626)

  • 1. Discovery research: the scientific challenge of finding new antibiotics.
    Livermore DM;
    J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
    Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibiotic resistome: challenge and opportunity for therapeutic intervention.
    Martínez JL
    Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination drugs, an emerging option for antibacterial therapy.
    Cottarel G; Wierzbowski J
    Trends Biotechnol; 2007 Dec; 25(12):547-55. PubMed ID: 17997179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global need for effective antibiotics-moving towards concerted action.
    Cars O; Hedin A; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):68-9. PubMed ID: 21444235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of natural products as a source of new antibiotics.
    Luzhetskyy A; Pelzer S; Bechthold A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):608-13. PubMed ID: 17668363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel target sites in bacteria for overcoming antibiotic resistance.
    Black MT; Hodgson J
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sources of novel antibiotics--aside the common roads.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics: where did we go wrong?
    Overbye KM; Barrett JF
    Drug Discov Today; 2005 Jan; 10(1):45-52. PubMed ID: 15676298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance.
    Bergström R
    Drug Resist Updat; 2011 Apr; 14(2):77-8. PubMed ID: 21493123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
    Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
    Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics in late clinical development.
    Fernandes P; Martens E
    Biochem Pharmacol; 2017 Jun; 133():152-163. PubMed ID: 27687641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.